University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Recent developments in salivary gland pathology after the WHO 2024 classification: new developments in existing entities and evolving new entities (2026) Skálová A, Laco J, Thompson LD, Bradová M, Vander Poorten V, Araújo ALD, Stenman G, et al. Journal article, Review article Negative pressure wound therapy made simple: expert panel recommendations (2026) Portou M, Bernaerts K, Bassetto F, Cherubino M, Collier M, Hirche C, Horch RE, et al. Journal article Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers (2026) Magno G, Rejeski K, Rappa G, Stock S, Holzem A, Landwehr M, Seib M, et al. Journal article Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies (2026) Panaccione R, Panés J, Peyrin-Biroulet L, Colombel JF, Lindsay JO, Baert F, Atreya R, et al. Journal article Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma (2026) Weeda YA, Salgado R, van Herpe F, Sur D, Vieth M, Loi S, Tafti AP, et al. Journal article, Review article Confocal Laser Endomicroscopy With Duodenal Food Challenge Does Not Predict Triggering Food Items in Eosinophilic Esophagitis: Results From a Pilot Trial (2026) Raymenants K, Balsiger LM, Schol J, van de Bruaene C, Tóth J, Dufour D, de Hertogh G, et al. Journal article Risk-based pathology reporting after endoscopic submucosal dissection for early gastrointestinal cancer: international consensus standards (2026) Khalaf K, Li H, Iwaya M, Orr CE, Schneider M, Iwaya Y, Yuan Y, et al. Journal article Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis (2026) Hohenfellner K, Wühl E, Haffner D, Weitzel D, Tsygin A, Trollmann R, Steidle G, et al. Journal article 18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis (2026) Quinn KA, Tan S, Verdijk P, Okonkwo L, Samson M, Blockmans D, Makhzoum JP, et al. Journal article A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis (2026) Makhzoum JP, Cid MC, Samson M, Henes J, Schönau V, Espigol-Frigole G, Ross C, et al. Journal article